Gender Differences in Respiratory Care
Pulmonary Vascular Disease in Women
Anna R. Hemnes, MD
Faculty Presentations
MeiLan K. Han, MD MS
Anna R. Hemnes, MD
Discussion
Pulmonary Vascular Disease in Women by Anna R. Hemnes, MD
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
Clinical Classification
Fig. 04 -
PAH
Fig. 05 -
Sex and PAH
Fig. 06 -
Heritable PAH
Fig. 07 -
Other PAH Subtypes
Fig. 08 -
Non-Group 1 PH
Fig. 09 -
Outcomes
Fig. 10 -
Adult PAH Survival: U.S.
Fig. 11 -
PAH Survival: France
Fig. 12 -
Genders respond differently
Fig. 13 -
Three Classic Pathways
Fig. 14 -
Responses to PAH Therapies
Fig. 15 -
Sex-Based Differences
Fig. 16 -
Sex Hormone Modulation
Fig. 17 -
Anastrozole
Fig. 18 -
Treatment in CTEPH
Fig. 19 -
Women Worse Survival
Fig. 20 -
Pregnancy in PAH
Fig. 21 -
Summary
« Prev
18 / 21
Next »
Print This Page
Enlarge Figure
Treatment in CTEPH Varies by Sex
References
[12]
Barco et al, Journal of Thrombosis and Haemostasis, 2019
« Prev
18 / 21
Next »
Apply For Credit